期刊文献+

牛磺酸上调基因1在肾癌组织的表达及临床意义

Expression of taurine up-regulated gene 1 and the clinical significance in renal cell carcinoma
原文传递
导出
摘要 目的:探讨牛磺酸上调基因1( TUG1)在肾癌组织及其配对癌旁正常组织中的表达,及其与临床病理特征之间的相关性。方法从46例经手术完整切除的肾癌组织及其配对癌旁正常组织中分别提取获得各自的总RNA,经逆转录得到cDNA,使用RTqPCR检测两者TUG1的表达,分析TUG1表达与患者临床病理特征的相关性。结果 TUG1在肾癌组织中的表达明显低于配对的癌旁正常组织(0.533±0.027、1.000±0.298),差异有统计学意义(t=-3.350,P<0.01)。46例肾癌组织中TUG1的△CT值经对数转换后最小值为-5.535,最大值3.085,平均值-0.908,以平均值-0.908为分界线,46例肾癌组织中有25例(54.34%)呈表达下调。 TUG1的表达水平与肾癌患者的年龄、性别、肾癌组织类型、TNM分期以及UICC/AJCC临床分期无显著相关性( P均>0.05)。结论肾癌组织中TUG1表达下调,提示其可能与肾癌的发生发展相关。 Objective To detect the expression level of Taurine upregulated gene 1( TUG1) in the renal cell carcinoma and paired paracancerous normal tissues,then explore the relationships between the expression level of TUG1 and clinical characteristics.Methods RNA was Extacted from the resected renal cell carcinoma tissues and paired paracancerous normal tissues of 46 patients respectively,by reverse transcription to get cDNA, the expression level of the TUG1 was detected by RTqPCR, the relationship between the expression level of TUG1 and the clinicopathological characteristics was analyzed by statistically software. Results The expression of TUG1 in renal cell carcinoma was obviously lower than that in paired paracancerous normal tissues(0.533±0. 027 vs. 1.000±0.298,t=-3.350,P〈0.01).The△CT value of Tug1 in 46 cases of renal cell carcinoma after logarithmic transformation,the minimum value was -5.535,maximum was 3.085,average value was -0.908,with the average of -0.908 as a dividing line,46 cases of renal cell carcinoma with 25 cases (54.34%) were down regulated the expression.The expression level of TUG1 of patients with renal carcinoma have no significant correlation with age,sex,type of renal cell carcinoma,TNM staging and UICC/AJCC staging(P〉0.05).Conclusion The expression of TUG1 in renal cell carcinoma tissues are downregulated,which also suggest that it may be related to the tumorigenesis and development of renal cell carcinoma.
出处 《中国综合临床》 2016年第9期776-779,共4页 Clinical Medicine of China
基金 国家自然科学基金项目(81101922) 深圳市科技研发资金知识创新基础研究项目(JCYJ20150403091443304)
关键词 肾癌 肿瘤分期 牛磺酸上调基因1 TAURINE up-regulated gene 1 Renal cell carcinoma Tumor stage Long non-coding RNA
  • 相关文献

参考文献16

  • 1Kuroda N, Karashima T, Inoue K, et al. Review of renal cell car- cinoma with rhab 被引量:1
  • 2Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer in- cidence and mortality patterns in Europe: estimates for 40 coun- tries in 2012 [ J~. Eur J Cancer, 2013, 49(6) : 1374-1403. 被引量:1
  • 3Ji Q,Zhang L, Liu X, et al. Long non-coding RNA MALAT1 pro- motes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PT- BP2 complex ~ J ]. Br J Cancer, 2014, 111 (4) : 736-748. 被引量:1
  • 4Tu ZQ, Li R J, Mei JZ, et al. Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carci- noma [J]. Int J Clin Exp Pathol, 2014, 7(7) : 4303-4309. 被引量:1
  • 5Martens-Uzunova ES, B~ttcher R, Croce CM, et al. Long noncod- ing RNA in prostate, bladder, and kidney cancer [ J]. Eur Urol, 2014, 65 (6) : 1140-1151. 被引量:1
  • 6Ellinger J, Alam J, Rothenburg J, et al. The long non-coding RNA Inc-ZNF180-2 is a prognostic biomarker in patients with clear cell renal cell carcinoma [J]. Am J Cancer Res, 2015, 5(9) : 2799- 2807. 被引量:1
  • 7Smolle M,Uranitsch S, Gerger A, et al. Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer [J]. Int J Mol Sci, 2014, 15(8) : 13993-14013. 被引量:1
  • 8Sun J,Ding C, Yang Z, et al. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes me- tastasis by affecting epithelial-mesenchymal transition [ J]. J Transl Med, 2016, 14( 1 ) : 42. 被引量:1
  • 9Li J, Zhang M, An G, et al. LncRNA TUG1 acts as a tumor sup- pressor in human glioma by promoting cell apoptosis [ J]. Exp Biol Med (Maywood), 2016, 241 (6): 644-649. 被引量:1
  • 10Huang MD, Chen WM, Qi FZ, et al, Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetieally silencing of KLF2 [ J ]. Mol Cancer, 2015, 14: 165. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部